Real-time enrollment status for this autism spectrum disorder clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 7:32 AM UTC
| NCT Number | NCT06706674 |
| Recruiting Status | Recruiting |
| Condition | Autism Spectrum Disorder |
| Phase | PHASE3 |
| Target Enrollment | 160 participants |
| Active Locations | 40 sites in the US |
| Sponsor | Intra-Cellular Therapies, Inc. |
| Last Updated on CT.gov | September 25, 2026 (2 weeks ago) |
As of October 15, 2026: Clinical trial NCT06706674 is currently recruiting participants. This phase3 study for autism spectrum disorder is actively seeking new participants at 40 locations across the United States. The study is sponsored by Intra-Cellular Therapies, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06706674 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 40 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06706674 was last updated 2 weeks ago (September 25, 2026). HelloStudys verifies this status automatically.